17,302 Shares in Trupanion, Inc. (NASDAQ:TRUP) Bought by Illinois Municipal Retirement Fund

Illinois Municipal Retirement Fund bought a new position in Trupanion, Inc. (NASDAQ:TRUP) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 17,302 shares of the financial services provider’s stock, valued at approximately $834,000.

Several other hedge funds also recently made changes to their positions in the company. Los Angeles Capital Management LLC increased its stake in shares of Trupanion by 28.5% in the fourth quarter. Los Angeles Capital Management LLC now owns 15,289 shares of the financial services provider’s stock worth $737,000 after buying an additional 3,390 shares during the period. Sigma Planning Corp increased its position in Trupanion by 50.0% during the 4th quarter. Sigma Planning Corp now owns 12,007 shares of the financial services provider’s stock valued at $579,000 after purchasing an additional 4,000 shares during the period. Handelsbanken Fonder AB increased its position in Trupanion by 40.7% during the 4th quarter. Handelsbanken Fonder AB now owns 8,300 shares of the financial services provider’s stock valued at $400,000 after purchasing an additional 2,400 shares during the period. Alberta Investment Management Corp purchased a new position in Trupanion during the 4th quarter valued at $781,000. Finally, New York State Common Retirement Fund increased its position in Trupanion by 5.8% during the 4th quarter. New York State Common Retirement Fund now owns 65,191 shares of the financial services provider’s stock valued at $3,142,000 after purchasing an additional 3,588 shares during the period.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the stock. Stifel Nicolaus reduced their price objective on shares of Trupanion from $44.00 to $41.00 and set a “hold” rating on the stock in a research report on Thursday, February 20th. Piper Sandler reduced their price objective on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a research report on Thursday, February 20th. Two analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, Trupanion has a consensus rating of “Moderate Buy” and a consensus price target of $46.60.

Insider Transactions at Trupanion

In related news, CFO Fawwad Qureshi sold 1,373 shares of the company’s stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $34.22, for a total value of $46,984.06. Following the transaction, the chief financial officer now owns 2,416 shares in the company, valued at $82,675.52. The trade was a 36.24 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 5.50% of the company’s stock.

Trupanion Stock Up 2.8 %

NASDAQ:TRUP opened at $34.54 on Monday. The firm’s 50-day moving average price is $45.87 and its 200-day moving average price is $47.89. The company has a market capitalization of $1.46 billion, a PE ratio of -150.17, a P/E/G ratio of 6.02 and a beta of 1.60. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.71 and a quick ratio of 1.66. Trupanion, Inc. has a 1-year low of $19.69 and a 1-year high of $57.90.

Trupanion (NASDAQ:TRUP) last released its earnings results on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). The business had revenue of $337.31 million during the quarter, compared to analysts’ expectations of $335.41 million. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. On average, equities analysts predict that Trupanion, Inc. will post 0.13 EPS for the current fiscal year.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.